Catheter Precision Showcases LockeT Device at International Symposium
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 06 2026
0mins
Should l Buy VTAK?
Source: Newsfilter
Catheter Precision Inc's stock price surged by 50.36% in pre-market trading as it crossed above the 5-day SMA.
The company showcased its LockeT suture retention device at the 2026 International Symposium on Left Atrial Appendage, highlighting its potential benefits for hospitals, including cost reduction and same-day discharge. CEO David Jenkins emphasized the device's growing recognition in the industry, particularly after its recent feature at a major conference, which underscores its efficiency and cost-effectiveness in clinical settings.
This event not only enhances the visibility of the LockeT device but also positions Catheter Precision as a leader in cardiac innovation, potentially attracting more interest from investors and healthcare professionals alike.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VTAK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VTAK
About VTAK
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. Its two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is also a technology-enabled regional air mobility company.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Flyte Expands Flight Capacity and Launches Hiring Initiative Following Spirit Airlines Shutdown
- Flight Capacity Increase: Flyte announced an increase in flight capacity following the shutdown of Spirit Airlines, planning to expand its Vision Jet fleet to meet rising domestic route demand, which is expected to enhance service availability and improve customer experience.
- Hiring Initiative Launched: Flyte has initiated a hiring program targeting pilots and aviation professionals affected by Spirit Airlines' exit, providing a structured onboarding and training pipeline to help industry talent transition smoothly into Flyte's operations.
- Market Response Analysis: The shutdown of Spirit Airlines has impacted approximately 17,000 employees, and Flyte anticipates attracting some displaced customers seeking short-haul travel alternatives, which may lead to higher fares and increased interest in alternative travel options.
- Strategic Expansion Direction: Flyte's expansion plans align with its existing growth strategy, aiming to optimize regional route coverage and enhance fleet utilization, thereby solidifying its competitive position in high-demand short-haul markets.
See More
CATHETER PRECISION INC - SPIRIT AIRLINES CLOSURE AFFECTS 17,000 WORKERS, INCLUDING MORE THAN 2,400 PILOTS
- Airline Shutdown: CATHETER PRECISION INC - SPIRIT AIRLINES has announced a shutdown affecting its operations.
- Employee Impact: The shutdown will impact 17,000 employees, including over 2,400 pilots.
See More
FLYTE EXPANDS CAPACITY AND INITIATES HIRING DRIVE AMID SPIRIT AIRLINES SHUTDOWN AFFECTING U.S. AIR TRAVEL
Flight Capacity Increase: Airlines are increasing their flight capacity to accommodate rising travel demand.
Shifting Travel Trends: The launch of new initiatives by airlines reflects changing patterns in U.S. air travel.
See More
Major Airlines Cut Routes, Creating Opportunities for Regional Air Mobility
- Market Structural Shift: As airlines cut short-haul routes due to rising fuel costs and operational constraints, Flyte is accelerating its expansion in short-haul markets, anticipating a multi-billion-dollar opportunity, particularly in critical travel corridors in the Northeast where demand remains strong.
- High-Frequency Service Advantage: Flyte utilizes the Cirrus Vision Jet to deliver high-frequency short-haul services, directly addressing the markets vacated by commercial airlines, optimizing flight frequency and scheduling flexibility to meet the needs of high-income and business travelers seeking rapid transit.
- Enhanced Economic Efficiency: Flyte's operational model reduces dependence on congested hub infrastructure, providing higher aircraft utilization and significantly lower fuel consumption per trip, ensuring competitiveness even as airlines raise ticket prices in response to increased operating costs.
- Continued Growth Expectations: As airlines continue to optimize for profitability, Flyte expects the reduction in short-haul service to persist, further enhancing its pricing power and market share in underserved regions.
See More
Catheter Precision Reports 60% Revenue Growth in Q4
- Significant Revenue Growth: Catheter Precision reported Q4 revenue of $0.24 million, reflecting a robust 60% year-over-year increase, indicating strong market performance and growth potential.
- Improved Net Loss: The company recorded a net loss of $5.3 million, an improvement from $5.6 million in 2024, suggesting enhanced cost control and operational efficiency.
- Equity Transaction Completed: Creatd sold its remaining stake in Fly Flyte to Catheter Precision for approximately $12 million in cash and equity, which will strengthen the latter's market position and resource integration capabilities.
- Enhanced Financial Transparency: Catheter Precision provided detailed financial information, boosting investor confidence in the company's future prospects and offering clearer decision-making insights for potential investors.
See More
Catheter Precision Secures $88 Million Financing for Growth
- Financing Amount: Catheter Precision, Inc. announced it has secured up to $88 million in new institutional financing aimed at accelerating growth, simplifying its balance sheet, and expanding its aviation and medical device operations, reflecting strong confidence in future development.
- Aviation Expansion: The newly acquired capital will be utilized by its aviation subsidiary, Flyte, Inc., to expand its fleet, acquire additional aircraft, and enter new regional markets, thereby enhancing the company's competitiveness in the air transport sector.
- Commitment to Medical Devices: In addition to aviation, Catheter Precision reaffirmed its commitment to its cardiac arrhythmia medical device business, with the financing providing resources to strengthen both divisions and enhance its capabilities in healthcare innovation.
- Stock Split Impact: The company executed a 1-for-19 reverse stock split on August 15, 2025, and although the stock is down 14.04% in pre-market trading, it still reflects a positive market response to the financing announcement.
See More
Flyte Expands Flight Capacity and Launches Hiring Initiative Following Spirit Airlines Shutdown
- Flight Capacity Increase: Flyte announced an increase in flight capacity following the shutdown of Spirit Airlines, planning to expand its Vision Jet fleet to meet rising domestic route demand, which is expected to enhance service availability and improve customer experience.
- Hiring Initiative Launched: Flyte has initiated a hiring program targeting pilots and aviation professionals affected by Spirit Airlines' exit, providing a structured onboarding and training pipeline to help industry talent transition smoothly into Flyte's operations.
- Market Response Analysis: The shutdown of Spirit Airlines has impacted approximately 17,000 employees, and Flyte anticipates attracting some displaced customers seeking short-haul travel alternatives, which may lead to higher fares and increased interest in alternative travel options.
- Strategic Expansion Direction: Flyte's expansion plans align with its existing growth strategy, aiming to optimize regional route coverage and enhance fleet utilization, thereby solidifying its competitive position in high-demand short-haul markets.
See More
CATHETER PRECISION INC - SPIRIT AIRLINES CLOSURE AFFECTS 17,000 WORKERS, INCLUDING MORE THAN 2,400 PILOTS
- Airline Shutdown: CATHETER PRECISION INC - SPIRIT AIRLINES has announced a shutdown affecting its operations.
- Employee Impact: The shutdown will impact 17,000 employees, including over 2,400 pilots.
See More
FLYTE EXPANDS CAPACITY AND INITIATES HIRING DRIVE AMID SPIRIT AIRLINES SHUTDOWN AFFECTING U.S. AIR TRAVEL
Flight Capacity Increase: Airlines are increasing their flight capacity to accommodate rising travel demand.
Shifting Travel Trends: The launch of new initiatives by airlines reflects changing patterns in U.S. air travel.
See More
Major Airlines Cut Routes, Creating Opportunities for Regional Air Mobility
- Market Structural Shift: As airlines cut short-haul routes due to rising fuel costs and operational constraints, Flyte is accelerating its expansion in short-haul markets, anticipating a multi-billion-dollar opportunity, particularly in critical travel corridors in the Northeast where demand remains strong.
- High-Frequency Service Advantage: Flyte utilizes the Cirrus Vision Jet to deliver high-frequency short-haul services, directly addressing the markets vacated by commercial airlines, optimizing flight frequency and scheduling flexibility to meet the needs of high-income and business travelers seeking rapid transit.
- Enhanced Economic Efficiency: Flyte's operational model reduces dependence on congested hub infrastructure, providing higher aircraft utilization and significantly lower fuel consumption per trip, ensuring competitiveness even as airlines raise ticket prices in response to increased operating costs.
- Continued Growth Expectations: As airlines continue to optimize for profitability, Flyte expects the reduction in short-haul service to persist, further enhancing its pricing power and market share in underserved regions.
See More
Catheter Precision Reports 60% Revenue Growth in Q4
- Significant Revenue Growth: Catheter Precision reported Q4 revenue of $0.24 million, reflecting a robust 60% year-over-year increase, indicating strong market performance and growth potential.
- Improved Net Loss: The company recorded a net loss of $5.3 million, an improvement from $5.6 million in 2024, suggesting enhanced cost control and operational efficiency.
- Equity Transaction Completed: Creatd sold its remaining stake in Fly Flyte to Catheter Precision for approximately $12 million in cash and equity, which will strengthen the latter's market position and resource integration capabilities.
- Enhanced Financial Transparency: Catheter Precision provided detailed financial information, boosting investor confidence in the company's future prospects and offering clearer decision-making insights for potential investors.
See More
Catheter Precision Secures $88 Million Financing for Growth
- Financing Amount: Catheter Precision, Inc. announced it has secured up to $88 million in new institutional financing aimed at accelerating growth, simplifying its balance sheet, and expanding its aviation and medical device operations, reflecting strong confidence in future development.
- Aviation Expansion: The newly acquired capital will be utilized by its aviation subsidiary, Flyte, Inc., to expand its fleet, acquire additional aircraft, and enter new regional markets, thereby enhancing the company's competitiveness in the air transport sector.
- Commitment to Medical Devices: In addition to aviation, Catheter Precision reaffirmed its commitment to its cardiac arrhythmia medical device business, with the financing providing resources to strengthen both divisions and enhance its capabilities in healthcare innovation.
- Stock Split Impact: The company executed a 1-for-19 reverse stock split on August 15, 2025, and although the stock is down 14.04% in pre-market trading, it still reflects a positive market response to the financing announcement.
See More
